French biopharm major picks Dubai for first Middle East office - Arabian Business
About - Ipsen
Ipsen en LinkedIn: At Ipsen we are committed to bringing innovative treatments to people…
Ipsen becomes a founding sponsor of the second Biolabs innovation hub in Europe at Hopital Hotel Dieu, AP-HP - Ipsen
PharmaShots Interview: Ipsen's Dr. Med. Steven Hildemann Shares Insight on the EC's Approval of Cabometyx + Nivolumab for Advanced Renal Cell Carcinoma
Ipsen - Innovation for patient care - Ipsen
Ipsen Adds Another Program Into Its Pre-Clinical R&D Oncology Pipeline Through an Exclusive Worldwide Collaboration With Accent Therapeutics, Targeting the RNA Modifying Protein, METTL3 | Business Wire
With New HQ, Ipsen to Rapidly Expand North American Presence | BioSpace
Applications now open for the 2023 Golden Ticket Competition
How Ipsen is making patient-centric innovation a reality - Ipsen
Big Bang North West 2019: IPSEN - Innovation for Patient Care | All About STEMAll About STEM
IpsenUS on Twitter: "Thanks to all who joined us for the grand opening of the Ipsen Innovation Center-Biolabs! It was an amazing night and we're grateful to all of the #biotech industry
With New HQ, Ipsen to Rapidly Expand North American Presence - NAI 500
IPSEN logo | Advance Systems Access Control
Innovation Archives - Ipsen
Ipsen launches regional headquarters | Omnia Health Insights
Ipsen (@IpsenGroup) / Twitter
Roche-Licensed Rare Disease Drug at Center of Ipsen's Up-to-$1.3B Clementia Acquisition
Ipsen announced overall Pharma Industry Company of the Year in 2021 Pharma Industry Awards - Ipsen UK
Ipsen finalizes purchase of Albireo Pharma to strengthen its rare disease portfolio | HealthCare Middle East & Africa Magazine
Ipsen | Pharma 50
Ipsen CEO steers clear of gene therapy despite rare disease push
Ipsen pharma - Ipsen pharma added a new photo. | Facebook
My Ipsen WP - Google Play'de Uygulamalar
Celebration of Ipsen Canadian Headquarters Grand Opening in Mississauga, Ontario - Ipsen
